Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-12

Clinical Trial Update: Evaluation of Preclinical Toxicity andTherapeutic Efficacy of Kandhaga Rasayanam in Padarthamarai [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of Phase 2 evaluation of Kandhaga Rasayanam in Padarthamarai for various tinea infections, focusing on preclin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kandhaga Rasayanam in Padarthamarai

Snippet

Sponsor: National institute of Siddha | Conditions: Tinea Infections Such as Tinea Corporis, Tinea Cruris, Tinea Pedis, Tinea Mannum, Tinea Barbae, Tinea Capitis Are Studied | Phase 2 | Status: COMPLETED